top of page
Timothy Schulz-Utermoehl, PhD
  • Drug discovery and DMPK expert with over 23 years in the pharma, biotech and CRO industry

  • Extensive neuroscience DMPK experience at MSD, AstraZeneca UK and Shire UK

  • Previous experience also includes Head of DMPK at Sygnature Discovery, Head of Preclinical Development at Chronos Therapeutics and COO at both Pandeia Therapeutics and Round Earth Therapeutics

Timothy Schulz-Utermoehl, PhD

Head of DMPK

bottom of page